Streetbeat News

Stock Prices

ABBV

AbbVie shares are trading lower after the company announced the acquisition of Celsius Therapeutics.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 4:44 pm

4502.JP

ASPHF

Ascentage Pharma Group International (OTC:ASPHF) has entered into a partnership with Takeda International, giving Takeda an option to market Ascentage's leukemia drug, olverembatinib, outside of China and Russia. The deal includes an initial payment of $100 million and potential milestone payments up to $1.2 billion. Takeda has also taken a 7.73% equity stake in Ascentage. This partnership alleviates Ascentage's liquidity crisis and boosts investor confidence, as evidenced by a significant rise in its stock price.

Portfolio Pulse from The Bamboo Works

June 27, 2024 | 4:43 pm

LNN

Lindsay shares are trading higher after the company reported better-than-expected Q3 EPS results.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 4:41 pm

ADBE

Adobe shares are trading higher amid strength in software stocks.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 4:41 pm

CVNA

NVO

RIVN

The article discusses the recent bullish moves in Novo Nordisk, Carvana, and Rivian, highlighting the pros and cons of trading options versus stocks. Novo Nordisk's stock surged after China approved its anti-obesity drug, Wegovy. Carvana's stock hit a 52-week high, benefiting from a call spread strategy. Rivian's shares rose significantly due to Volkswagen's $5 billion investment.

Portfolio Pulse from David Pinsen

June 27, 2024 | 4:39 pm

GRFS

Grifols expects its leverage ratio to decrease to 5.4x by the end of June 2024, down from 6.8x in March 2024, due to SRAAS proceeds. The company anticipates positive free cash flow in Q2 2024, contributing to its FY24 guidance of €5 million, which includes €480 million of extraordinary items. By the end of June, liquidity is expected to exceed €2.4 billion, including SRAAS proceeds. Grifols is a completely separate entity from Scranton, with none of Scranton's liabilities consolidated in the company's group.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 4:37 pm

NGNE

Neurogene shares are trading higher after BMO Capital initiated coverage on the stock with an Outperform rating and announced a $65 price target.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 4:35 pm

LEVI

MU

SPY

WBA

Levi Strauss, Walgreens, and Micron experienced drops in their stock prices following their earnings reports. The GDP growth slightly exceeded estimates, and a presidential debate is scheduled for 9:00 p.m. ET.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 4:34 pm

LNZA

LanzaTech Global shares are trading higher following the company's announcement of the launch of CirculAir.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 4:32 pm

DXC

IBM

KD

Kyndryl Holdings Inc (NYSE:KD) shares rose after news of a potential joint bid for DXC Technology Co (NYSE:DXC). Oppenheimer's Ian Zaffino initiated coverage with an Outperform rating and a $33 price target, citing revenue growth, margin expansion, and earnings projections. The company has repriced legacy contracts and struck deals with major hyperscalers.

Portfolio Pulse from Priya Nigam

June 27, 2024 | 4:31 pm